Endothelin-1 inactivating peptidase in the human kidney and urine

Journal of Hypertension

Volumn 18, Issue 4, 2000, Pages 475-483

  Janas, Jadwiga ^a   Sitkiewicz, Dariusz ^a   Januszewicz, Andrzej ^b   Szczesniak, Cezary ^c   Grenda, Ryszard ^a   Janas, Roman M ^d  

^a Department of Clinical Biochemistry ^*  (Poland)

^b INSTITUTE OF CARDIOLOGY   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Acidic metalloprotease; Endothelin antagonists; Endothelin metabolism; Hypertension; Neutral endopeptidase; Renal failure; Urinary peptidases

Indexed keywords

ANGIOTENSIN; ANILINE DERIVATIVE; ATRIAL NATRIURETIC FACTOR; BRADYKININ; CHOLECYSTOKININ; CITRIC ACID; CYCLOSPORIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; ENKEPHALIN; ENZYME INHIBITOR; GASTRIN; NEUROPEPTIDE Y; PEPTIDASE; PHENANTHROLINE; PHOSPHATE; PHOSPHORAMIDON; SUBSTANCE P; THIORPHAN; TRICHLOROACETIC ACID;

ADOLESCENT; ADULT; ARTICLE; BINDING AFFINITY; CENTRIFUGATION; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY ALLOGRAFT; PH; PRECIPITATION; PRIORITY JOURNAL; SOLUBILIZATION; ULTRAFILTRATION; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

EID: 0034091228     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018040-00018     Document Type: Article

References (30)

1. 1 Janas J, Sitkiewicz D, Warnawin K, Janas RM. Characterization of a novel, high-molecular weight, acidic, endothelin-1 inactivating metalloendopeptidase from the rat kidney. J Hypertens 1994; 12:1155-1162.
2. 2 Brown M, Chou S-Y, Porush JG. Endothelin and kidney diseases. Nephron 1996; 72:375-382.
3. 3 Nord EP. Role of endothelin in acute renal failure. Blood Purification 1997; 15:273-285.
4. 4 Haynes WG, Webb DJ. Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 1998; 16:1081-1098.
5. 5 Ruschitzka F, Corti R, Noll G, Luscher TF. A rationale for treatment of endothelial dysfunction in hypertension. J Hypertens 1999; 17(Suppl 1):S25-S35.
6. 6 Firth JD, Tatcliffe PJ. Organ distribution of the three rat endothelin messenger RNA's and the effects of ischaemia on renal gene expression. J Clin Invest 1992; 90:1023-1031.
7. 7 Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, et al. ECE-1: a membrane-bound metalloprotease that catalyses the proteolytic activation of big endothelin-1. Cell 1994; 78:473-485.
8. 8 Disaschi T, Nonoguchi H, Iwaoka T, Naomi S, Nakayama Y, Shimada K, et al. Endothelin converting enzyme-1 gene expression in the kidney of spontaneously hypertensive rat. Hypertension 1997; 30:1591-1597.
9. 9 Neri Serneri GG, Modesti PA, Cecioni I, Biagini D, Migliorini A, Costoli A, et al. Plasma endothelin and renal endothelin are two distinct systems involved in volume homeostasis. Am J Physiol 1995; 268:H1829-H1837.
10. 10 Modesti PA, Cecioni I, Naldoni A, Migliorini A, Neri Serneri GG. Relationship of renin-angiotensin system and ET-1 system activation in log-lasting response to postural changes. Am J Physiol 1996; 270:H1200-1206.
11. 11 Remuzzi G, Benigni A. Endothelins in the control of cardiovascular and renal function. Lancet 1993; 342:589-593.
12. 12 Takeda M, Komeyama T, Tsutsui T, Mizusawa T, Go H, Tamaki M, et al. Changes in urinary excretion of endothelin-1-like immunoreactivity before and after unilateral nephrectomy in humans: comparison with other urinary parameters and unilateral adrenalectomy. Nephron 1994; 67:180-184.
13. 13 Hoffman A, Grossman E, Goldstein DS, Gill JR, Keiser HR. Urinary excretion rate of endothelin-1 in patient with essential hypertension and salt sensitivity. Kidney Int 1994; 45:556-560.
14. 14 DeFeo ML, La Villa G, Lazzeri C, Tosti-Guerra C, Becorpi A, Pupilli C, et al. Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans. Hypertension 1997; 29:70-74.
15. 15 Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 1994; 46:325-415.
16. 16 Turner AJ. Endopeptidase-24.11 and neuropeptide metabolism. In: Turner AJ (editor): Neuropeptides and their peptidases. Chichester: Ellis Horwood; 1987:183-201.
17. 17 Sokolovsky M, Galron R, Kloog Y, Bdolah A, Indig FE, Blumberg S, et al. Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc Natl Acad Sci USA 1990; 87:4702-4706.
18. 18 Vijayaraghavan J, Scicli AG, Carretero OA, Slaughter C, Moomaw C, Hersh LB. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem 1990; 265:14150-14155.
19. 19 Abassi ZA, Golomb E, Bridenbaugh R, Keiser HR. Metabolism of endothelin-1 by recombinant neutral endopeptidase EC 3.4.24.11. Br J Pharmacol 1993; 109:1024-1028.
20. 20 Janas J, Sitkiewicz D, Pulawska MF, Warnawin K, Janas RM. Purification of endothelin-1 inactivating peptidase from the rat kidney. J Hypertens 1994; 12:375-382.
21. 21 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
22. 22 Kenny AJ, Stephenson SL. Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide. FEBS Lett 1988; 232:1-8.
23. 5]enkephalin. Gastroenterology 1988; 95:952-957.
24. 24 Roques BP, Noble F, Daug V, Furnie-Zaluski M-C, Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 1993; 45:870146.
25. 25 Roques BP. Zinc metallopeptidases: active site structure and design of selective and mixed inhibitors. New approaches in the search for analgesics and anti-hypertensivnes. Biochem Soc Trans 1993; 21:678-685.
26. 26 Avin R, Gurbanov K, Hoffman A, Blumberg S, Winaver J. Urinary neutral endopeptidase 24.11 activity: Modulation by chronic salt loading. Kidney Int 1995; 47:855-860.
27. 27 Abassi ZA, Pieruzzi F, Nakhoul F, Keiser HR. Effect of cyclosporin A on the synthesis, excretion and metabolism of endothelin in the rat. Hypertension 1996; 27:1140-1148.
28. 28 Emoto N, Yanagisawa M. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 1995; 270:15262-15268.
29. 29 Cowley AW, Mattson DL, Lu S, Roman RJ. The renal medulla and hypertension. Hypertension 1995; 25[part 2]:663-673.
30. 30 Di Marco GS, Quinto BMR, Juliano M, Carmona AK, Stella RCR, Plavnik FL, et al. Purification and characterization of a neutral endopeptidase-like enzyme from human urine. J Hypertens 1998; 16:1971-1978.